Pure Biosciences (PURE) Files $50M Mixed Shelf
Pure Biosciences (Nasdaq: PURE) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $50 million of Preferred Stock, Common Stock, Warrants, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MyoKardia (MYOK) to Offer 3.8M Shares
- New Mountain Finance (NMFC) Announces Additional Conv. Notes Offering
- Mylan (MYL) Offers U.S. EpiPen Profitability Analysis; Sees Gross Margin at 75% for 2016
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!